يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"Carlos, Ruth C."', وقت الاستعلام: 0.89s تنقيح النتائج
  1. 1
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Obeng‐gyasi, Samilia; Kircher, Sheetal M.; Lipking, Kelsey P.; Keele, Benjamin J.; Benson, Al B.; Wagner, Lynne I.; Carlos, Ruth C. (2019). "Oncology clinical trials and insurance coverage: An update in a tenuous insurance landscape." Cancer (20): 3488-3493.; https://hdl.handle.net/2027.42/151873Test; Cancer; Centers for Medicare and Medicaid Services. Affordable Care Act implementation FAQsâ set 15. https://www.cms.gov/CCIIO/Resources/FAct-Sheets-and-FAQs/aca_implementation_faqs15.htmlTest. Published 2018. Accessed February 27, 2018.; Singh GK, Williams SD, Siahpush M, Mulhollen A. Socioeconomic, ruralâ urban, and racial inequalities in US cancer mortality: part Iâ all cancers and lung cancer and part IIâ colorectal, prostate, breast, and cervical cancers. J Cancer Epidemiol. 2011; 2011: 107497.; Silber JH, Rosenbaum PR, Ross RN, et al. Disparities in breast cancer survival by socioeconomic status despite Medicare and Medicaid insurance. Milbank Q. 2018; 96: 706 â 754.; Ayanian JZ, Kohler BA, Abe T, Epstein AM. The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med. 1993; 329: 326 â 331.; Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B. Treatment variation by insurance status for breast cancer patients. Breast J. 2008; 14: 128 â 134.; Halpern MT, Bian J, Ward EM, Schrag NM, Chen AY. Insurance status and stage of cancer at diagnosis among women with breast cancer. Cancer. 2007; 110: 403 â 411.; Bradley CJ, Given CW, Roberts C. Disparities in cancer diagnosis and survival. Cancer. 2001; 91: 178 â 188.; Oâ Malley CD, Shema SJ, Clarke LS, Clarke CA, Perkins CI. Medicaid status and stage at diagnosis of cervical cancer. Am J Public Health. 2006; 96: 2179 â 2185.; Halpern MT, Ward EM, Pavluck AL, Schrag NM, Bian J, Chen AY. Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis. Lancet Oncol. 2008; 9: 222 â 231.; Mahal BA, Aizer AA, Ziehr DR, et al. The association between insurance status and prostate cancer outcomes: implications for the Affordable Care Act. Prostate Cancer Prostatic Dis. 2014; 17: 273 â 279.; Goldman DP, Berry SH, McCabe MS, et al. Incremental treatment costs in National Cancer Instituteâ sponsored clinical trials. JAMA. 2003; 289: 2970 â 2977.; Wagner JL, Alberts SR, Sloan JA, et al. Incremental costs of enrolling cancer patients in clinical trials: a populationâ based study. J Natl Cancer Inst. 1999; 91: 847 â 853.; Fireman BH, Fehrenbacher L, Gruskin EP, Ray GT. Cost of care for patients in cancer clinical trials. J Natl Cancer Inst. 2000; 92: 136 â 142.; American Society of Clinical Oncology. Affordable Care Act and coverage of clinical trials: frequently asked questions. https://www.asco.org/sites/new-www.asco.org/files/content-files/research-and-progress/documents/faq-clinical-trials-coverage-statute.pdfTest. Published 2012. Accessed February 19, 2018.; Persad G. Priority setting, costâ effectiveness, and the Affordable Care Act. Am J Law Med. 2015; 41: 119 â 166.; Kircher SM, Benson AB III, Farber M, Nimeiri HS. Effect of the Accountable Care Act of 2010 on clinical trial insurance coverage. J Clin Oncol. 2012; 30: 548 â 553.; American Society of Clinical Oncology. Insurance coverage of clinical trials. https://www.asco.org/research-progress/clinical-trials/insurance-coverage-clinical-trialsTest. Published 2017. Accessed April 21, 2017.; Edge SB, Zwelling LA, Hohn DC. The anticipated and unintended consequences of the Patient Protection and Affordable Care Act on cancer research. Cancer J. 2010; 16: 606 â 613.; Jain N, Steensma D, Stewart DJ, Kantarjian H. Insurance denial of coverage for patients enrolled in cancer clinical trials is still a problem in the Affordable Care Act era. J Oncol Pract. 2016; 12: 283 â 285.; Gross CP, Murthy V, Li Y, Kaluzny AD, Krumholz HM. Cancer trial enrollment after stateâ mandated reimbursement. J Natl Cancer Inst. 2004; 96: 1063 â 1069.; Klamerus JF, Bruinooge SS, Ye X, et al. The impact of insurance on access to cancer clinical trials at a comprehensive cancer center. Clin Cancer Res. 2010; 16: 5997 â 6003.; Martel CL, Li Y, Beckett L, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer J. 2004; 10: 294 â 300.; Claxton G, Rae M, Long M, Damico A, Sawyer B. Grandfathered health plans. https://www.kff.org/report-section/ehbs-2016-section-thirteen-grandfathered-health-plansTest/. Updated September 14, 2016. Accessed March 4, 2018.; Mackay CB, Gurleyâ Calvez T, Erickson KD, Jensen RA. Clinical trial insurance coverage for cancer patients under the Affordable Care Act. Contemp Clin Trials Commun. 2016; 2: 69 â 74.; Kehl KL, Fullmer CP, Fu S, et al. Insurance clearance for earlyâ phase oncology clinical trials following the Affordable Care Act. Clin Cancer Res. 2017; 23: 4155 â 4162.; Mackay CB, Antonelli KR, Bruinooge SS, Saint Onge JM, Ellis SD. Insurance denials for cancer clinical trial participation after the Affordable Care Act mandate. Cancer. 2017; 123: 2893 â 2900.; Sommers BD, Clark KL, Epstein AM. Early changes in health insurance coverage under the Trump administration. N Engl J Med. 2018; 378: 1061 â 1063.; Bell JA, Balneaves LG. Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients’ relational autonomy. Support Care Cancer. 2015; 23: 1169 â 1196.; Hamel LM, Penner LA, Albrecht TL, Heath E, Gwede CK, Eggly S. Barriers to clinical trial enrollment in racial and ethnic minority patients with cancer. Cancer Control. 2016; 23: 327 â 337.; Lara PN Jr, Higdon R, Lim N, et al. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment. J Clin Oncol. 2001; 19: 1728 â 1733.; Lara PN Jr, Paterniti DA, Chiechi C, et al. Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials. J Clin Oncol. 2005; 23: 9282 â 9289.; Simon MS, Du W, Flaherty L, et al. Factors associated with breast cancer clinical trials participation and enrollment at a large academic medical center. J Clin Oncol. 2004; 22: 2046 â 2052.; Tournoux C, Katsahian S, Chevret S, Levy V. Factors influencing inclusion of patients with malignancies in clinical trials. Cancer. 2006; 106: 258 â 270.; Michaels M, Dâ Agostino TA, Blakeney N, et al. Impact of primary care provider knowledge, attitudes, and beliefs about cancer clinical trials: implications for referral, education and advocacy. J Cancer Educ. 2015; 30: 152 â 157.; Comis RL, Miller JD, Colaizzi DD, Kimmel LG. Physicianâ related factors involved in patient decisions to enroll onto cancer clinical trials. J Oncol Pract. 2009; 5: 50 â 56.; Chow CJ, Habermann EB, Abraham A, et al. Does enrollment in cancer trials improve survival? J Am Coll Surg. 2013; 216: 774 â 780; discussion 780â 771.; Unger JM, Barlow WE, Martin DP, et al. Comparison of survival outcomes among cancer patients treated in and out of clinical trials. J Natl Cancer Inst. 2014; 106: dju002.; Unger JM, LeBlanc M, Blanke CD. The effect of positive SWOG treatment trials on survival of patients with cancer in the US population. JAMA Oncol. 2017; 3: 1345 â 1351.; Ford JG, Howerton MW, Lai GY, et al. Barriers to recruiting underrepresented populations to cancer clinical trials: a systematic review. Cancer. 2008; 112: 228 â 242.; Duma N, Vera Aguilera J, Paludo J, et al. Representation of minorities and women in oncology clinical trials: review of the past 14 years. J Oncol Pract. 2018; 14: e1 â e10.; Balducci L. Studying cancer treatment in the elderly patient population. Cancer Control. 2014; 21: 215 â 220.; Unger JM, Coltman CA Jr, Crowley JJ, et al. Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. J Clin Oncol. 2006; 24: 141 â 144.; Denson AC, Mahipal A. Participation of the elderly population in clinical trials: barriers and solutions. Cancer Control. 2014; 21: 209 â 214.; Arnold K, Vastag B. Medicare to cover routine care costs in clinical trials. J Natl Cancer Inst. 2000; 92: 1032.; Gross CP, Wong N, Dubin JA, Mayne ST, Krumholz HM. Enrollment of older persons in cancer trials after the Medicare reimbursement policy change. Arch Intern Med. 2005; 165: 1514 â 1520.; Louis CJ, Clark JR, Hillemeier MM, Camacho F, Yao N, Anderson RT. The effects of hospital characteristics on delays in breast cancer diagnosis in Appalachian communities: a populationâ based study. J Rural Health. 2018; 34 ( suppl 1 ): s91 â s103.; Quaglia A, Lillini R, Mamo C, Ivaldi E, Vercelli M. Socioâ economic inequalities: a review of methodological issues and the relationships with cancer survival. Crit Rev Oncol Hematol. 2013; 85: 266 â 277.

  2. 2
    دورية أكاديمية
  3. 3
    دورية أكاديمية
  4. 4
    دورية أكاديمية

    المصدر: Journal of the American College of Radiology; Apr2017, Vol. 14 Issue 4, p482-487.e5, 1p